DCIS, ductal carcinoma in situ, breast cancer, deep learning, AI, recurrence prediction, prognostication
dcis, Shared decision making, patient preference
ductal carcinoma in situ, knowledge, information provision, shared decision making
oligometastatic breast cancer, homologous recombination deficiency, intensified alkylating chemotherapy, multimodality treatment